Rabies vaccine batch check: will it pass the test?
NCT ID NCT07416110
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether three different batches of a rabies vaccine work the same way and are safe. It involves 912 healthy adults aged 18 to 45. The goal is to make sure every batch produces a strong immune response.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- rabies vaccine (Vero cell, freeze-dried)
- What this could lead to
- If successful, this could confirm that the vaccine is consistently effective and safe, supporting its wider use to prevent rabies after exposure.
- What could go wrong
- This trial only checks consistency between batches, not whether the vaccine prevents rabies itself. It is also in healthy volunteers, so results may not apply to people with weakened immune systems.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RABIES (HEALTHY VOLUNTEERS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mianzhu Municipal Center for Disease Control and Prevention
Deyang, China
-
Neijiang Municipal Center for Disease Control and Prevention
Neijiang, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Rabies vaccine booster still effective after 5 years, study to confirm
- New rabies shot could shield millions after bites
- New rabies vaccine schedule tested in 2,000 volunteers
- New rabies vaccine shows promise in preventing deadly infection
- Promising new rabies vaccine passes phase 3 test
- New rabies vaccine shows promise in large thai trial